Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|June 23, 2025
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phasesNina Le Bert, Apostolos Koffas, Rajneesh Kumar, et al.JHEP Reports : Innovation in Hepatology|February 18, 2026
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BMarzia Rossi, Andrea Vecchi, Camilla Tiezzi, et al.Journal of Hepatology|December 11, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis deltaElisabetta Degasperi, Caroline Scholtes, Barbara Testoni, et al.Alimentary Pharmacology & Therapeutics|August 28, 2025
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective StudyRaffaella Viganò, Alessandro Loglio, Clara Dibenedetto, et al.Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.The American Journal of Gastroenterology|August 16, 2022
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varicesVincenza Calvaruso, Ciro Celsa, Roberta D'Ambrosio, et al.Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.Journal of Hepatology|March 9, 2023
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis BIlaria Montali, Camilla Ceccatelli Berti, Marco Morselli, et al.JHEP Reports : Innovation in Hepatology|February 11, 2020
Liver fibrosis and CD206<sup>+</sup> macrophage accumulation are suppressed by anti-GM-CSF therapyAlfonso Tan-Garcia, Fritz Lai, Joe Poh Sheng Yeong, et al.Journal of Hepatology|November 21, 2020
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapyJulia Dietz, Velia Chiara Di Maio, Adolfo de Salazar, et al.Pageof 9